Skip to main content
. 2024 Apr 2;7(4):e244525. doi: 10.1001/jamanetworkopen.2024.4525

Table 2. IRs per 10 000 Person-Years and aHRs of Depression, Anxiety, or Stress-Related Disorders .

Biomarkera Depression, anxiety, or stress-related disorders Depression Anxiety Stress-related disorders
No. of events (IR) aHR (95% CI) No. of events (IR) aHR (95% CI) No. of events (IR) aHR (95% CI) No. of events (IR) aHR (95% CI)
High glucose (≥6.11 mmol/L)
Yes 622 (41.5) 1.30 (1.20-1.41) 416 (27.4) 1.36 (1.23-1.50) 261 (17.0) 1.22 (1.08-1.38) 130 (8.5) 1.25 (1.04-1.49)
No 13 455 (36.2) 1.0 [Reference] 7949 (21.1) 1.0 [Reference] 6338 (16.7) 1.0 [Reference] 4164 (10.9) 1.0 [Reference]
High total cholesterol (≥5.00 mmol/L)
Yes 8987 (35.1) 1.01 (0.98-1.05) 5532 (21.3) 1.00 (0.95-1.05) 4154 (15.9) 1.04 (0.99-1.10) 2248 (8.6) 1.00 (0.94-1.06)
No 5575 (38.4) 1.0 [Reference] 3151 (21.4) 1.0 [Reference] 2662 (17.9) 1.0 [Reference] 2157 (14.5) 1.0 [Reference]
High triglycerides (≥1.71 mmol/L)
Yes 2497 (36.2) 1.15 (1.10-1.20) 1608 (23.0) 1.18 (1.12-1.25) 1132 (16.1) 1.16 (1.09-1.24) 645 (9.15) 1.21 (1.11-1.32)
No 11 982 (36.3) 1.0 [Reference] 7030 (21.0) 1.0 [Reference] 5644 (16.7) 1.0 [Reference] 3735 (11.0) 1.0 [Reference]
High LDL-C (≥3.00 mmol/L)
Yes 3973 (33.8) 1.01 (0.95-1.06) 2459 (20.7) 0.98 (0.91-1.06) 1810 (15.1) 0.99 (0.91-1.07) 945 (7.9) 0.98 (0.88-1.08)
No 2234 (37.0) 1.0 [Reference] 1279 (20.9) Ref 1087 (17.7) Ref 834 (13.5) Ref
High HDL-C (≥1.03 mmol/L)
Yes 6019 (34.8) 0.88 (0.80-0.97) 3583 (20.4) 0.91 (0.80-1.03) 2820 (16.0) 0.78 (0.68-0.90) 1762 (10.0) 0.87 (0.72-1.05)
No 448 (33.2) 1.0 [Reference] 271 (19.8) 1.0 [Reference] 228 (16.6) 1.0 [Reference] 122 (8.8) 1.0 [Reference]
High LDL-C/HDL-C ratio (≥3.50)
Yes 701 (31.6) 1.06 (0.97-1.14) 444 (19.8) 1.04 (0.94-1.15) 325 (14.4) 1.10 (0.98-1.24) 139 (6.2) 0.97 (0.81-1.16)
No 5 252 (35.3) 1.0 [Reference] 3114 (20.7) 1.0 [Reference] 2465 (16.3) 1.0 [Reference] 1591 (10.4) 1.0 [Reference]
High ApoA-I (≥1.00 mmol/L in men and 1.10 mmol/L in women)
Yes 5269 (34.3) 0.92 (0.78-1.10) 3155 (20.3) 0.83 (0.67-1.03) 2502 (16.0) 1.04 (0.80-1.35) 1499 (9.6) 0.88 (0.66-1.19)
No 135 (37.4) 1.0 [Reference] 88 (24.1) 1.0 [Reference] 58 (15.7) 1.0 [Reference] 45 (12.2) 1.0 [Reference]
High ApoB (≥0.90 mmol/L)
Yes 3574 (32.9) 0.95 (0.88-1.02) 2159 (19.7) 0.94 (0.85-1.04) 1690 (15.3) 1.02 (0.91-1.13) 901 (8.1) 0.86 (0.76-0.98)
No 1001 (37.6) 1.0 [Reference] 548 (20.2) 1.0 [Reference] 463 (17.0) 1.0 [Reference] 405 (14.8) 1.0 [Reference]
High ApoB/ApoA-I ratio (≥0.90 in men and 0.80 in women)
Yes 1599 (32.9) 1.06 (0.99-1.13) 984 (20.0) 1.04 (0.96-1.14) 765 (15.5) 1.12 (1.01-1.23) 355 (7.2) 1.00 (0.87-1.14)
No 2207 (33.2) 1.0 [Reference] 1274 (18.9) 1.0 [Reference] 1043 (15.4) 1.0 [Reference] 715 (10.5) 1.0 [Reference]

Abbreviations: aHR, adjusted hazard ratio; ApoA-I, apolipoprotein A-I; ApoB, apolipoprotein B; HDL-C, high-density lipoprotein cholesterol; IR, incidence rate; LDL-C, low-density lipoprotein cholesterol.

SI conversion factors: To convert glucose to milligrams per deciliter, divide by 0.0555; to convert total cholesterol, HDL-C, and LDL-C to milligrams per deciliter, divide by 0.0259; to convert triglycerides to milligrams per deciliter, divide by 0.0113; to convert ApoA-I and ApoB to milligrams per deciliter, multiply by 0.01.

a

Adjusted for age at first blood sampling, sex, fasting status at first blood sampling, country of birth, and socioeconomic status.